Gritstone Oncology announced the appointment of Jean-Marc Bellemin as Executive Vice President of Finance and Chief Financial Officer, effective January 5, 2018. Mr. Bellemin will lead company's finance, accounting and investor relations functions, as well as Human Resources and Information Technology. He will report to Andrew Allen, M.D., Ph.D., President and CEO of company, and will be based in the company's headquarters in Emeryville, CA.

Mr. Bellemin brings more than 23 years of international experience in finance and operations management within start-up and global commercial pharmaceutical organizations. Most recently, he was Senior Vice President and Chief Financial Officer of Actelion Pharmaceuticals USA, providing strategic leadership, plus financial and operations management of an international, profitable, publicly-traded biotechnology company. He led the long-term strategic process for the finance, project management, information technology and market access functions at Actelion until its acquisition by Johnson & Johnson in 2017.